Abstract
The in vitro activities of six fluoroquinolones were determined against 1482 Enterococcus species isolates collected as part of a 1996 Canadian surveillance study. Clinafloxacin MIC90s were 4 or 8 microg/mL, trovafloxacin and BAY 12-8039 MIC90s were 8 or 16 microg/mL, sparfloxacin MIC90s were 32 microg/mL, and ciprofloxacin and ofloxacin MIC90s were >32 microg/mL for the vancomycin-sensitive Enterococcus faecalis, vancomycin-sensitive Enterococcus faecium, and vancomycin-resistant E. faecium isolates collected.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Anti-Bacterial Agents / pharmacology*
-
Anti-Infective Agents / pharmacology*
-
Aza Compounds*
-
Canada
-
Ciprofloxacin / pharmacology
-
Drug Resistance, Microbial
-
Enterococcus / drug effects*
-
Enterococcus / isolation & purification
-
Fluoroquinolones*
-
Humans
-
Microbial Sensitivity Tests
-
Moxifloxacin
-
Naphthyridines / pharmacology
-
Ofloxacin / pharmacology
-
Quinolines*
-
Quinolones / pharmacology
-
Vancomycin / pharmacology*
Substances
-
Anti-Bacterial Agents
-
Anti-Infective Agents
-
Aza Compounds
-
Fluoroquinolones
-
Naphthyridines
-
Quinolines
-
Quinolones
-
Ciprofloxacin
-
Vancomycin
-
clinafloxacin
-
trovafloxacin
-
Ofloxacin
-
sparfloxacin
-
Moxifloxacin